PUBLISHER: DelveInsight | PRODUCT CODE: 1618264
PUBLISHER: DelveInsight | PRODUCT CODE: 1618264
Foot Drop Treatment Devices Market by Product Type (Electrical Stimulator and Braces/Splints), Application (Neuropathy, Muscle Disorders, Brain & Spinal Disorders, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the rising prevalence of chronic neurological disorders and the growing cases of lower limb pain worldwide
The foot drop treatment devices market is projected to grow at a CAGR of 8.15% during the forecast period from 2024 to 2030. The foot drop treatment devices market is observing substantial market growth primarily owing to the rising prevalence of chronic neurological disorders including multiple sclerosis, growing cases of lower limb pain, and the rising geriatric population that are expected to escalate the overall growth of the foot drop treatment devices market during the forecast period from 2024 to 2030.
Foot Drop Treatment Devices Market Dynamics:
As per data from the World Health Organization (WHO) (2023), it was reported that over 1.8 million people worldwide are affected by multiple sclerosis. It impacts various functions including cognitive, emotional, motor, sensory, and visual abilities. It occurs when the immune system mistakenly attacks the brain and the spinal cord. The prevalence of multiple sclerosis significantly drives the demand for foot drop treatment devices, as multiple sclerosis often leads to motor impairments, including foot drop. The condition disrupts mobility and independence, requiring advanced solutions like functional electrical stimulators to restore gait.
As per data provided by the WHO 2021, between 2015 and 2050, people falling between 60 years and above will be doubled from 12 to 22%, and will eventually reach 2.1 billion by 2050, globally. Moreover, by 2030, 1 in 6 people will age 60 years or above. The aging global population increases the prevalence of age-related conditions like stroke, peripheral neuropathy, and degenerative disorders, which are major causes of foot drop. This drives the demand for treatment devices to enhance mobility and improve the quality of life in elderly individuals.
Therefore, all the factors stated above collectively will drive the overall foot drop treatment devices market growth.
However, the side effects associated with prolonged usage, fitting-related issues, and others may prove to be challenging factors for the foot drop treatment devices market growth during the forecast period.
Foot Drop Treatment Devices Market Segment Analysis:
Foot Drop Treatment Devices Market by Product Type (Electrical Stimulator and Braces/Splints), Application (Neuropathy, Muscle Disorders, Brain & Spinal Disorders, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product type segment of the foot drop treatment devices, the electrical stimulator category is expected to have a significant revenue share in the year 2023. This is due to their non-invasive nature, ability to restore functional movement, and effectiveness in re-educating muscles.
These devices use advanced functional electrical stimulation technology to activate dorsiflexor muscles, improving gait and reducing the risk of falls. Their portability, customization options, and compatibility with wearable designs make them convenient for daily use. Additionally, the increasing awareness about their therapeutic benefits and their application in rehabilitation for neurological conditions like stroke and multiple sclerosis is further expected to drive their adoption.
Therefore, the widespread uses and key features of electrical stimulators that enhance their performance are solidifying the impact on the growth of the overall foot drop treatment devices market, during the forecast period from 2024 to 2030.
North America is expected to dominate the overall foot drop treatment devices market:
Among all the regions, North America is expected to dominate the foot drop treatment devices market in the year 2023 and is expected to do the same during the forecast period. This can be attributed to several factors including the high instances of guillain-barre syndrome, increasing cases of lower limb pain combined with significant advancements in product development & regulatory approvals, the presence of market key players, and the availability of well-established advanced healthcare infrastructure; acting as key factors contributing to the growth of the foot drop treatment devices market in the North America region during the forecast period from 2024 to 2030.
According to data from the Centers of Disease Control and Prevention (2023), it was stated that guillain-barre syndrome is a rare disorder in which the body's immune system mistakenly attacks the peripheral nerves. This damage to the nerves leads to muscle weakness and, in some cases, paralysis. In the United States, an estimated 3,000 to 6,000 people develop guillain-barre syndrome each year. Thus the rising cases of guillain-barre syndrome is increasing demand for foot drop treatment devices as guillain-barre syndrome often causes nerve damage leading to muscle weakness and foot drop.
Further, the Centre for Disease Control and Prevention (2021), stated that the percentage of adults experiencing lower limb pain rose with age, starting at 21.0% for individuals aged 18-29, increasing to 28.8% for those aged 30-44, 43.4% for adults aged 45-64, and reaching 50.3% for those aged 65 and over. The increasing prevalence of lower limb pain with age is driving the demand for foot drop treatment devices. As more individuals experience knee issues or age-related pain, the likelihood of developing foot drop increases, creating a larger patient base for assistive devices to improve mobility and quality of life.
Additionally, the prompt and well-established healthcare services and infrastructure further contribute to the growth of the regional foot drop treatment devices market growth. The presence of key players with their strong distribution networks ensures widespread availability and accessibility of these devices across the region, thus increasing their revenue shares in the market, along with supportive reimbursement programs providing immense growth opportunities for the same.
Therefore, the interplay of all the aforementioned factors would provide a conducive growth environment for the North American foot drop treatment devices market.
Foot Drop Treatment Devices Market key players:
Some of the key market players operating in the foot drop treatment devices market include Ottobock, Bioness Inc, AxioBionics, Saebo, Inc., OrthoPediatrics Corp., Turbomed Orthotics, Ossur, Thrive Orthopedics, Allard USA Inc., NextStep Robotics, Arthrex, Inc., Evolution Devices, Narang Medical Limited, AliMed, Cionic, and others.
Recent Developmental Activities in the Foot Drop Treatment Devices Market:
Key Takeaways from the Foot Drop Treatment Devices Market Report Study
Target Audience who can be benefited from this Foot Drop Treatment Devices Market Report Study
Frequently Asked Questions for the Foot Drop Treatment Devices Market: